This investigation is for anyone who acquired securities in Corcept Therapeutics, Inc. (NASDAQ: CORT) from August 2, 2017 through February 5, 2019.
The Law Offices of Howard G. Smith believes that the Company and certain of its executives violated federal law. Specifically, the Law Offices of Howard G. Smith believes that, during the time period mentioned above, the Company misled investors regarding its financial condition. More specifically, the Law Offices of Howard G. Smith believes that the Company misled investors to believe that the sales of its lone drug, Korlym, was based on the efficacy of the drug and therefore stainable when, in fact, the Company was paying doctors kickbacks to prescribe the drug for off-label uses.
On January 25, 2019, Southern Investigative Reporting Foundation (SIRF) published a report alleging that Corcept paid doctors to prescribe its drug, Korlym, for off-label uses from 2016 through 2017. The report condemned the Company for exploiting regulatory loopholes, charging patients an excessive price for its lone drug product, and touting evidence for the drug's effectiveness that -- according to SIRF – doesn't exist. On this news, the price of the Company's stock dropped precipitously on unusually heavy trading volume. Then , on February 5, 2019, Blue Orca Capital published an article alleging that the Company had only one distributor, a related party pharmacy, and that it used its relationship to artificially increase its sales. On this news, the price of the Company's stock again dropped on unusually heavy trading volume.
The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Corcept Therapeutics, Inc. (NASDAQ: CORT) from August 2, 2017 through February 5, 2019 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.
Join the Class Action
First Name: *
Last Name: *
If Representing an Institution, Name of Institution:
If Representing an Institution, Position at Institution:
Mailing Address: *
Phone #: *
I, the Plaintiff, certify that:
1. I have reviewed the Complaint and authorized its filing.
2. Plaintiff did not purchase the security that is the subject of this
action, at the direction of plaintiff's counsel or in order to
participate in any private action arising under this title.
3. I am willing to serve as a representative party on behalf of a class
and will testify at deposition and trial, if necessary.
4. My transactions in the securities, which are the subject of this
action, during the Class Period set forth in the Complaint are as
5. I have not served as a representative party on behalf of a class
under the federal security laws during the last three years, except
if detailed below.
6. I will not accept any payment for serving as a representative party,
except to receive my pro rata share of any recovery or as ordered
or approved by the court including the award to a representative
plaintiff of reasonable costs and expenses (including lost wages)
directly relating to the representation of the class.
agreement and retain the Law Offices of Howard G. Smith and its associates to proceed on Plaintiff's behalf, on a contingent fee basis. If I am executing this agreement on behalf of an institution, I further certify that I am authorized to execute this agreement on behalf of the institution.